These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 9630249)

  • 1. Regulated tissue-specific expression of antagonistic pre-mRNA splicing factors.
    Hanamura A; Cáceres JF; Mayeda A; Franza BR; Krainer AR
    RNA; 1998 Apr; 4(4):430-44. PubMed ID: 9630249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF.
    Mayeda A; Helfman DM; Krainer AR
    Mol Cell Biol; 1993 May; 13(5):2993-3001. PubMed ID: 8474457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selection of alternative 5' splice sites: role of U1 snRNP and models for the antagonistic effects of SF2/ASF and hnRNP A1.
    Eperon IC; Makarova OV; Mayeda A; Munroe SH; Cáceres JF; Hayward DG; Krainer AR
    Mol Cell Biol; 2000 Nov; 20(22):8303-18. PubMed ID: 11046128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing of the adenylyl cyclase stimulatory G-protein G alpha(s) is regulated by SF2/ASF and heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) and involves the use of an unusual TG 3'-splice Site.
    Pollard AJ; Krainer AR; Robson SC; Europe-Finner GN
    J Biol Chem; 2002 May; 277(18):15241-51. PubMed ID: 11825891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506.
    Pilch B; Allemand E; Facompré M; Bailly C; Riou JF; Soret J; Tazi J
    Cancer Res; 2001 Sep; 61(18):6876-84. PubMed ID: 11559564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. hnRNP A1 and the SR proteins ASF/SF2 and SC35 have antagonistic functions in splicing of beta-tropomyosin exon 6B.
    Expert-Bezançon A; Sureau A; Durosay P; Salesse R; Groeneveld H; Lecaer JP; Marie J
    J Biol Chem; 2004 Sep; 279(37):38249-59. PubMed ID: 15208309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HnRNP A1/A2 and SF2/ASF regulate alternative splicing of interferon regulatory factor-3 and affect immunomodulatory functions in human non-small cell lung cancer cells.
    Guo R; Li Y; Ning J; Sun D; Lin L; Liu X
    PLoS One; 2013; 8(4):e62729. PubMed ID: 23658645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors.
    Cáceres JF; Stamm S; Helfman DM; Krainer AR
    Science; 1994 Sep; 265(5179):1706-9. PubMed ID: 8085156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Both phosphorylation and dephosphorylation of ASF/SF2 are required for pre-mRNA splicing in vitro.
    Cao W; Jamison SF; Garcia-Blanco MA
    RNA; 1997 Dec; 3(12):1456-67. PubMed ID: 9404896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of the SR proteins ASF/SF2 and SC35 influences alternative splicing in vivo in diverse ways.
    Wang J; Manley JL
    RNA; 1995 May; 1(3):335-46. PubMed ID: 7489505
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spatio-temporal expression of the trans-acting splicing factors SF2/ASF and heterogeneous ribonuclear proteins A1/A1B in the myometrium of the pregnant human uterus: a molecular mechanism for regulating regional protein isoform expression in vivo.
    Pollard AJ; Sparey C; Robson SC; Krainer AR; Europe-Finner GN
    J Clin Endocrinol Metab; 2000 May; 85(5):1928-36. PubMed ID: 10843177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative amounts of antagonistic splicing factors, hnRNP A1 and ASF/SF2, change during neoplastic lung growth: implications for pre-mRNA processing.
    Zerbe LK; Pino I; Pio R; Cosper PF; Dwyer-Nield LD; Meyer AM; Port JD; Montuenga LM; Malkinson AM
    Mol Carcinog; 2004 Dec; 41(4):187-96. PubMed ID: 15390079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2.
    Mayeda A; Krainer AR
    Cell; 1992 Jan; 68(2):365-75. PubMed ID: 1531115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation.
    Petersen-Mahrt SK; Estmer C; Ohrmalm C; Matthews DA; Russell WC; Akusjärvi G
    EMBO J; 1999 Feb; 18(4):1014-24. PubMed ID: 10022843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Roles for SR proteins and hnRNP A1 in the regulation of c-src exon N1.
    Rooke N; Markovtsov V; Cagavi E; Black DL
    Mol Cell Biol; 2003 Mar; 23(6):1874-84. PubMed ID: 12612063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The second RNA-binding domain of the human splicing factor ASF/SF2 is the critical domain controlling adenovirus E1A alternative 5'-splice site selection.
    Dauksaite V; Akusjärvi G
    Biochem J; 2004 Jul; 381(Pt 2):343-50. PubMed ID: 15068396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential ASF/SF2 activity in extracts from normal WI38 and transformed WI38VA13 cells.
    Chabot B; Frappier D; La Branche H
    Nucleic Acids Res; 1992 Oct; 20(19):5197-204. PubMed ID: 1408834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific commitment of different pre-mRNAs to splicing by single SR proteins.
    Fu XD
    Nature; 1993 Sep; 365(6441):82-5. PubMed ID: 8361546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exonic splicing enhancer-dependent selection of the bovine papillomavirus type 1 nucleotide 3225 3' splice site can be rescued in a cell lacking splicing factor ASF/SF2 through activation of the phosphatidylinositol 3-kinase/Akt pathway.
    Liu X; Mayeda A; Tao M; Zheng ZM
    J Virol; 2003 Feb; 77(3):2105-15. PubMed ID: 12525645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The SR splicing factors ASF/SF2 and SC35 have antagonistic effects on intronic enhancer-dependent splicing of the beta-tropomyosin alternative exon 6A.
    Gallego ME; Gattoni R; Stévenin J; Marie J; Expert-Bezançon A
    EMBO J; 1997 Apr; 16(7):1772-84. PubMed ID: 9130721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.